Kincell Bio Welcomes Industry Veteran Mark R. Bamforth as Chief Executive Officer to Drive Business Growth Research Triangle Park,…
INCATE and Kineticos extend partnership to support startups combating Antimicrobial Resistance December 16, 2024 – INCATE (the INCubator for Antibacterial Therapies…
)
Kineticos Portfolio Company Inceptor Bio Announces Strategic Partnership for Next-Generation Solid Tumor CAR-T December 18, 2024 –Inceptor Bio, a leading…
)
Endolytix Closed on Additional Financing with New Investment from the Kineticos AMR Accelerator Fund I October 29, 2024 – Kineticos…
){kind=logo}
The Kineticos AMR Accelerator Fund I Invests in Orthobond Kineticos Strategic Advisor Steve Favaloro will join Orthobond’s Board of Directors…
Kincell Bio Announces New Board Chairman Mark R. Bamforth to Accelerate Company’s Growth and Expansion May 21st 2024 – Kincell Bio,…
)
EnteroBiotix Completes £27m Financing Round to Advance Clinical Trials, Initiates Phase 2 Study of EBX-102-02 in Patients with Irritable Bowl…
Kineticos and INCATE join forces in supporting AMR innovators December 6th 2023 – INCATE (the INCubator for Antibacterial Therapies in…
Kineticos Life Sciences Announces Successful Final Close of approximately $60 Million for Kineticos Disruptor Fund II RALEIGH, N.C. | November…